U.S. Physical Therapy, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 495.02M | 553.14M | 604.80M | 671.35M | 780.99M | 16.3% | |
| Cost of Revenue | (377.84M) | (441.12M) | (483.29M) | (547.42M) | (623.65M) | 13.9% | |
Gross Profit | 117.18M | 112.02M | 121.51M | 123.92M | 157.34M | 27.0% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (46.53M) | (46.11M) | — | (58.29M) | — | -100.0% | |
| Depreciation & Amortization | (11.59M) | (14.74M) | (15.70M) | (18.68M) | (22.39M) | 19.9% | |
Operating Income (EBIT) | 70.65M | 56.80M | 52.06M | 63.21M | 80.43M | 27.2% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | 3.77M | 3.94M | 105.00K | -97.3% | |
| Interest Expense | (942.00K) | (5.78M) | (9.30M) | (8.02M) | (9.46M) | 18.0% | |
| Other Income/Expenses (Net) | 2.55M | -1.23M | -2.69M | -3.00M | -2.62M | -12.8% | |
Income Before Tax | 73.20M | 55.57M | 49.38M | 60.21M | 77.81M | 29.2% | |
| Income Tax Expense | (15.27M) | (12.16M) | (12.16M) | (14.61M) | (19.81M) | 35.6% | |
Net Income | 27.82M | 28.27M | 14.67M | 26.46M | 15.06M | -43.1% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $4 | $3 | $1 | $2 | $1 | -22.8% | |
| Weighted Avg Shares Outstanding | 12.90M | 12.98M | 14.19M | 15.06M | 15.18M | 0.7% | |
| Weighted Avg Shares Outstanding (Diluted) | 12.90M | 12.98M | 14.19M | 15.06M | 15.18M | 0.7% | |
EBITDA | 85.73M | 76.09M | 74.37M | 86.91M | 109.66M | 26.2% |
Explore USPH
USPH in the Healthcare
Small Cap